Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration

被引:93
作者
Drolet, RE
Behrouz, B
Lookingland, KJ
Goudreau, JL [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA
[3] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA
关键词
Parkinson's disease; MPTP; alpha-synuclein; dopamine;
D O I
10.1016/j.neuro.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The functional role of a-synuclein in the pathogenesis of Parkinson's disease (PD) is not fully understood. Systemic exposure of alpha-synuclein-deficient mice to neurotoxins provides a direct approach to evaluate how alpha-synuclein may mediate cell death in a common marine model of PD. To this end, wild-type and homozygous alpha-synuclein knock-out mice were treated with sub-chronic and prolonged, chronic exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the sub-chronic model, wild-type and a-synuclein knock-out mice were treated for five consecutive days with MPTP (1-25 mg/kg, s.c.) or vehicle, and sacrificed 3 days,following the last injection. The prolonged, chronic model consisted of two injections of MPTP (1-20 mg/kg, s.c.) per week for 5 weeks, with co-administration of probenecid (250 mg/kg, i.p.), and animals were sacrificed 3 weeks following the last injection. Sub-chronic administration of MPTP caused a dramatic, dose-dependent decrease in striatal dopamine (DA) concentrations, while an attenuated response was observed in a-synuclein knock-out mice. Similarly, prolonged, chronic administration of MPTP produced a dose-dependent decrease in striatal DA concentrations, and a corresponding loss of striatal vesicular monoamine transporter (VMAT-2) protein in wild-type mice. However mice lacking alpha-synuclein had an attenuated loss of striatal DA concentrations, while no loss of striatal VMAT-2 protein was observed. Both sub-chronic and prolonged, chronic administration of MPTP caused an increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) to DA ratio in wild-type mice, but not in mice lacking a-synuclein. Despite attenuated toxicity, elevated lactate concentrations were observed in alpha-synuclein knock-out mice following prolonged, chronic MPTP administration. The results of this study provide evidence that alpha-synuclein null mice have an attenuated response to the toxic effects of MPTP exposure, even over prolonged periods of time and that the biochemical sequela of a protracted insult to nigrostriatal DA neurons are distinct between mice with and without alpha-synuclein expression. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 39 条
  • [31] L-DOPA does not cause neurotoxicity in VMAT2 heterozygote knockout mice
    Reveron, ME
    Savelieva, KV
    Tillerson, JL
    McCormack, AL
    Di Monte, DA
    Miller, GW
    [J]. NEUROTOXICOLOGY, 2002, 23 (4-5) : 611 - 619
  • [32] Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine-induced parkinsonism in mice
    Schlüter, OM
    Fornai, F
    Alessandri, MG
    Takamori, S
    Geppert, M
    Jahn, R
    Südhof, TC
    [J]. NEUROSCIENCE, 2003, 118 (04) : 985 - 1002
  • [33] α-synuclein locus triplication causes Parkinson's disease
    Singleton, AB
    Farrer, M
    Johnson, J
    Singleton, A
    Hague, S
    Kachergus, J
    Hulihan, M
    Peuralinna, T
    Dutra, A
    Nussbaum, R
    Lincoln, S
    Crawley, A
    Hanson, M
    Maraganore, D
    Adler, C
    Cookson, MR
    Muenter, M
    Baptista, M
    Miller, D
    Blancato, J
    Hardy, J
    Gwinn-Hardy, K
    [J]. SCIENCE, 2003, 302 (5646) : 841 - 841
  • [34] Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia
    Smeyne, M
    Goloubeva, O
    Smeyne, RJ
    [J]. GLIA, 2001, 34 (02) : 73 - 80
  • [35] alpha-synuclein in Lewy bodies
    Spillantini, MG
    Schmidt, ML
    Lee, VMY
    Trojanowski, JQ
    Jakes, R
    Goedert, M
    [J]. NATURE, 1997, 388 (6645) : 839 - 840
  • [36] In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
    Tatton, NA
    Kish, SJ
    [J]. NEUROSCIENCE, 1997, 77 (04) : 1037 - 1048
  • [37] WESTERINK BHC, 1982, BRAIN RES, V252, P239, DOI 10.1016/0006-8993(82)90391-2
  • [38] Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease
    Wilson, JM
    Levey, AI
    Rajput, A
    Ang, L
    Guttman, M
    Shannak, K
    Niznik, HB
    Hornykiewicz, O
    Pifl, C
    Kish, SJ
    [J]. NEUROLOGY, 1996, 47 (03) : 718 - 726
  • [39] Wilson JM, 1996, J NEUROSCI, V16, P3507